IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2016-08-15 16:30 After Market Close:IMPRIMIS PHARMA Earning Release 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-06-17 AccNo: 0001493152-16-010938 Size: 27 KBItem 1.02: Termination of a Material Definitive Agreement 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-06-15 AccNo: 0001493152-16-010842 Size: 34 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-06-07 AccNo: 0001493152-16-010569 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-05-12 AccNo: 0001493152-16-009684 Size: 92 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-12 AccNo: 0001493152-16-009683 Size: 4 MB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2016-05-12 16:30 After Market Close:IMPRIMIS PHARMA Earning Release 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-04-27 AccNo: 0001354488-16-007114 Size: 64 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-27 AccNo: 0001354488-16-007113 Size: 679 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2016-04-26 AccNo: 0001493152-16-009186 Size: 752 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem...